0000812796-13-000001.txt : 20130503 0000812796-13-000001.hdr.sgml : 20130503 20130503113637 ACCESSION NUMBER: 0000812796-13-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20130503 DATE AS OF CHANGE: 20130503 EFFECTIVENESS DATE: 20130503 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SOLIGENIX, INC. CENTRAL INDEX KEY: 0000812796 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 411505029 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-195945 FILM NUMBER: 13811135 BUSINESS ADDRESS: STREET 1: 29 EMMONS DRIVE STREET 2: SUITE C-10 CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: 609-538-8200 MAIL ADDRESS: STREET 1: 29 EMMONS DRIVE STREET 2: SUITE C-10 CITY: PRINCETON STATE: NJ ZIP: 08540 FORMER COMPANY: FORMER CONFORMED NAME: DOR BIOPHARMA INC DATE OF NAME CHANGE: 20020329 FORMER COMPANY: FORMER CONFORMED NAME: ENDOREX CORP DATE OF NAME CHANGE: 19960916 FORMER COMPANY: FORMER CONFORMED NAME: IMMUNOTHERAPEUTICS INC DATE OF NAME CHANGE: 19920703 D 1 primary_doc.xml X0706 D LIVE 0000812796 SOLIGENIX, INC. 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ NEW JERSEY 08540 609-538-8200 DELAWARE DOR BIOPHARMA INC ENDOREX CORP IMMUNOTHERAPEUTICS INC Corporation true Christopher J. Schaber, Ph.D. c/o Soligenix, Inc. 29 Emmons Drive, Suite C-10 Princeton NJ NEW JERSEY 08540 Executive Officer Director Keith L. Brownlie, C.P.A. c/o Soligenix, Inc. 29 Emmons Drive, Suite C-10 Princeton NJ NEW JERSEY 08540 Director Gregg A. Lapointe, C.P.A. c/o Soligenix, Inc. 29 Emmons Drive, Suite C-10 Princeton NJ NEW JERSEY 08540 Director Robert J. Rubin, M.D. c/o Soligenix, Inc. 29 Emmons Drive, Suite C-10 Princeton NJ NEW JERSEY 08540 Director Jerome B. Zeldis, M.D., Ph.D. c/o Soligenix, Inc. 29 Emmons Drive, Suite C-10 Princeton NJ NEW JERSEY 08540 Director Robert N. Brey, Ph.D. c/o Soligenix, Inc. 29 Emmons Drive, Suite C-10 Princeton NJ NEW JERSEY 08540 Executive Officer Kevin J. Horgan, M.D. c/o Soligenix, Inc. 29 Emmons Drive, Suite C-10 Princeton NJ NEW JERSEY 08540 Executive Officer Joseph M. Warusz, C.P.A. c/o Soligenix, Inc. 29 Emmons Drive, Suite C-10 Princeton NJ NEW JERSEY 08540 Executive Officer Biotechnology $1,000,001 - $5,000,000 06 false 2013-04-27 false true false 0 1500000 1500000 0 The Company issued 1,034,483 shares of common stock to Intrexon Corp pursuant to an Exclusive Channel Collaboration Agreement. No cash was received. The amount entered is based solely on the closing price of the Company's common stock of $1.45 on 4/26/13. false 1 0 0 0 false SOLIGENIX, INC. /s/ Christopher J. Schaber Christopher J. Schaber, Ph.D. President and Chief Executive Officer 2013-05-03